Monoclonal Antibody Treatment in Long-Term Care Settings

Posted on January 6, 2021 by Kari Everson

Monoclonal antibody treatment is an IV infusion that, when given to qualifying residents, works to decrease the severity of disease and prevent hospitalization from COVID-19. MDH has a REDCap survey for providers to complete when requesting doses of monoclonal antibody (mAbs) therapy. After completion of the REDCap survey, the Minnesota Department of Health (MDH) will reach out to organizations and ensure they have appropriate protocols in place to safely administer mAbs therapy.

MDH noted some barriers with preparation to LeadingAge staff during a call last week.We created a Monoclonal Antibody Therapy Considerations resource to assist with preparing to administer mAbs treatment within long-term care organizations. Additionally, AMDA/ASCP developed a longer document discussing Monoclonal Antibody Treatments in Senior Care Environments.

For further information or questions about mAbs treatment, please contact Kari Everson – keverson@leadingagemn.org